法国关于诊断和管理巨细胞动脉炎的协议
Hubert de Boysson1, Valérie Devauchelle-Pensec2, Christian Agard3
1Department of Internal Medicine, Caen University Hospital, Caen, France.
La Revue de medecine interne
|November 1, 2024
概括
巨细胞动脉炎 (GCA) 是一种影响老年妇女的大血管血管炎. 早期诊断和紧急治疗,主要是用皮质类固醇,对于预防视力丧失和长期并发症至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 血管医学 血管医学
- 内部医学 内部医学
背景情况:
- 巨细胞动脉炎 (GCA) 是一种流行的大血管血管炎,主要影响50岁以上的女性.
- 它通常会影响外动脉的分支,导致头痛,头皮敏感和关节硬化.
- 眼科并发症,包括缺血性视神经病变和视网膜中枢动脉封闭,构成永久失明的重大风险.
研究的目的:
- 总结巨细胞动脉炎 (GCA) 诊断,治疗和管理的关键方面.
- 突出早期干预和多学科合作在预防严重后果方面的重要性.
- 强调全科医生在患者护理途径中的作用.
主要方法:
- 诊断依赖于临床表现,成像 (FDG-PET/CT,CTA,MRA) 和动脉活检.
- 多普勒超声波和血管成像也用于诊断确认.
- 多发性肌痛风湿症经常与GCA相关.
主要成果:
- 高剂量的皮质类固醇 (例如,普雷尼松) 是首选的初始治疗方法.
- 托西利祖马布可以与普得尼松一起用于皮质类固醇缓解效应.
- 长期管理需要监测疾病复发和治疗副作用.
结论:
- 在怀疑GCA或存在眼科症状时,迫切需要紧急治疗,以防止视力丧失.
- 大约40%的患者经历了主动脉或分支干扰,往往无症状,但预后不佳.
- 一般医生和专家之间的持续警和合作对于管理长期风险至关重要,包括心血管事件,即使在疾病缓解后.
相关概念视频
01:21Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
142
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
142